Immunosuppressive treatment for acquired haemophilia: Current practice and future directions in Germany, Austria and Switzerland

Annals of Hematology

Volumn 88, Issue 4, 2009, Pages 365-370

  Tiede, Andreas ^a   Huth Kühne, Angela ^b   Oldenburg, Johannes ^c   Großmann, Ralf ^d   Geisen, Ulrich ^e   Krause, Manuela ^f   Brand, Brigit ^g   Alberio, Lorenzo ^h   Klamroth, Robert ⁱ   Spannagl, Michael ^j   Knöbl, Paul ^k  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SRH Kurpfalzhospital   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ Vivantes Klinikum Friedrichshain   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Acquired haemophilia; Autoimmunity; Cyclophosphamide; Glucocorticoids; Immunosuppressive agents; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; RITUXIMAB; STEROID;

ARTICLE; AUSTRIA; BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GERMANY; HEALTH SURVEY; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REMISSION; SWITZERLAND; TREATMENT CONTRAINDICATION;

ANTIBODIES, MONOCLONAL; AUSTRIA; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; DATA COLLECTION; GERMANY; HEMOPHILIA A; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; PHYSICIAN'S PRACTICE PATTERNS; REMISSION INDUCTION; STEROIDS; SWITZERLAND; TREATMENT FAILURE;

EID: 60749101203     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0665-7     Document Type: Article

References (8)

1. Collins PW (2007) Treatment of acquired hemophilia A. J Thromb Haemost 5:893-900 doi: 10.1111/j.1538-7836.2007.02433.x
2. Franchini M, Lippi G (2008) How I treat acquired factor VIII inhibitors. Blood 112(2):250-255 doi: 10.1182/blood-2008-03-143586
3. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121:21-35 doi: 10.1046/ j.1365-2141.2003.04162.x
4. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR (2007) Acquired hemophilia A in the United Kingdom: A 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 109:1870-1877 doi: 10.1182/blood-2006-06-029850
5. Watling M (2004) The European acquired haemophilia registry. Blood Coagul Fibrinolysis 15(Suppl. 1):29 doi: 10.1097/00001721-200405001-00006
6. Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, Vetter H, Brackmann HH (2005) Treatment of acquired hemophilia by the Bonn-Malmo Protocol: Documentation of an in vivo immunomodulating concept. Blood 105:2287-2293 doi: 10.1182/blood-2004-05-1811
7. Baudo F, Levesque H, Huth-Kühne A, Knoebl P, Marco P, Nemes L, Peerlinck K, Tengborn L (2008) The European Acquired Hemophilia Registry (EACH2): A preliminary data analysis. Haemophilia 14(Suppl. 2):1
8. Sperr WR, Lechner K, Pabinger I (2007) Rituximab for the treatment of acquired antibodies to factor VIII. Haematologica 92:66-71 doi: 10.3324/ haematol.10553